Figures & data
Figure 1. Model diagram of the seasonal influenza transmission and vaccination.
![Figure 1. Model diagram of the seasonal influenza transmission and vaccination.](/cms/asset/71b60a9c-8495-4b40-bd7e-991f6f329874/khvi_a_2348124_f0001_oc.jpg)
Table 1. Description of epidemiological parameters and baseline values.
Table 2. Input data for cost, utilities, and disutilities used in the cost-effectiveness analysis.
Table 3. Health outcomes and overall costs (USD, $) for each seasonal influenza vaccination strategy.
Table 4. Effects of vaccinating all individuals with QIV versus aQIV administration for adults ≥65 years on incremental costs (USD, $), incremental QALYs, and ICERs ($/QALY).
Figure 2. Cost-effectiveness acceptability curves depicting the cost-effective probability of aQIV versus QIV based on the efficacy of aQIV.
![Figure 2. Cost-effectiveness acceptability curves depicting the cost-effective probability of aQIV versus QIV based on the efficacy of aQIV.](/cms/asset/be27abc6-0fca-47ad-abd6-760657d62c70/khvi_a_2348124_f0002_oc.jpg)
Figure 3. One-way deterministic sensitivity analysis.
![Figure 3. One-way deterministic sensitivity analysis.](/cms/asset/c806b15c-8606-4aaf-b2d0-d2e2a37215e7/khvi_a_2348124_f0003_oc.jpg)
Figure 4. Incremental cost-effectiveness ratios based on the total vaccination costs.
![Figure 4. Incremental cost-effectiveness ratios based on the total vaccination costs.](/cms/asset/2dfc9fc3-36da-4c06-a4e2-b1c87a2cfc09/khvi_a_2348124_f0004_oc.jpg)